Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 93

1.

The assessment of clinicopathological features, therapy pattern and survival benefit of 162 gastric cancers with liver metastases.

Li J, Lu M, Li J, Zhang X, Li Y, Zhan X, Shen L.

Hepatogastroenterology. 2013 May;60(123):628-32.

PMID:
23108083
2.

Adenocarcinoma in the middle third of the stomach--an evaluation for the prognostic significance of clinicopathological features.

Sheen-Chen SM, Chou CW, Chen MC, Chen FC, Chen YS, Chen JJ.

Hepatogastroenterology. 1997 Sep-Oct;44(17):1488-94.

PMID:
9356878
3.

Hepatic resection for synchronous hepatic metastasis from gastric cancer.

Qiu JL, Deng MG, Li W, Zou RH, Li BK, Zheng Y, Lao XM, Zhou K, Yuan YF.

Eur J Surg Oncol. 2013 Jul;39(7):694-700. doi: 10.1016/j.ejso.2013.03.006. Epub 2013 Apr 8.

PMID:
23579173
4.

Liver resection for gastric cancer metastases.

Viganò L, Vellone M, Ferrero A, Giuliante F, Nuzzo G, Capussotti L.

Hepatogastroenterology. 2013 May;60(123):557-62.

PMID:
23635434
5.

Outcome of patients with colorectal liver metastasis: analysis of 1,613 consecutive cases.

Dexiang Z, Li R, Ye W, Haifu W, Yunshi Z, Qinghai Y, Shenyong Z, Bo X, Li L, Xiangou P, Haohao L, Lechi Y, Tianshu L, Jia F, Xinyu Q, Jianmin X.

Ann Surg Oncol. 2012 Sep;19(9):2860-8. doi: 10.1245/s10434-012-2356-9. Epub 2012 Apr 12.

PMID:
22526903
6.

Survival of gastric cancer with concomitant liver metastases.

Kwok CM, Wu CW, Lo SS, Shen KH, Hsieh MC, Lui WY.

Hepatogastroenterology. 2004 Sep-Oct;51(59):1527-30.

PMID:
15362793
7.

Clinical benefit of surgical management for gastric cancer with synchronous liver metastasis.

Aizawa M, Nashimoto A, Yabusaki H, Nakagawa S, Matsuki A.

Hepatogastroenterology. 2014 Jul-Aug;61(133):1439-45.

PMID:
25436322
8.

Liver resection for metastatic gastric cancer.

Thelen A, Jonas S, Benckert C, Lopez-Hänninen E, Neumann U, Rudolph B, Schumacher G, Neuhaus P.

Eur J Surg Oncol. 2008 Dec;34(12):1328-34. doi: 10.1016/j.ejso.2008.01.022. Epub 2008 Mar 10.

PMID:
18329229
9.

Repetitive transarterial chemoembolization (TACE) of liver metastases from gastric cancer: local control and survival results.

Vogl TJ, Gruber-Rouh T, Eichler K, Nour-Eldin NE, Trojan J, Zangos S, Naguib NN.

Eur J Radiol. 2013 Feb;82(2):258-63. doi: 10.1016/j.ejrad.2012.10.006. Epub 2012 Nov 3.

PMID:
23127803
10.

Prognostic factors for survival in patients with hepatic recurrence after curative resection of gastric cancer.

Hwang SE, Yang DH, Kim CY.

World J Surg. 2009 Jul;33(7):1468-72. doi: 10.1007/s00268-009-0034-2.

PMID:
19381718
11.

[Prognostic analysis of 220 colorectal cancer patients with synchronous liver metastases].

He YF, Li YH, Zhang DS, Xiang XJ, Xu RH, Pan ZZ, Zhou ZW, Jiang WQ, He YJ, Wan DS.

Ai Zheng. 2006 Sep;25(9):1153-7. Chinese.

PMID:
16965661
12.

A reliable risk score for stage IV esophagogastric cancer.

Blank S, Lordick F, Dobritz M, Grenacher L, Burian M, Langer R, Roth W, Schaible A, Becker K, Bläker H, Sisic L, Stange A, Compani P, Schulze-Bergkamen H, Jäger D, Büchler M, Siewert JR, Ott K.

Eur J Surg Oncol. 2013 Aug;39(8):823-30. doi: 10.1016/j.ejso.2013.01.005. Epub 2013 Jan 31.

PMID:
23375470
13.

Indication for hepatic resection in the treatment of liver metastasis from gastric cancer.

Makino H, Kunisaki C, Izumisawa Y, Tokuhisa M, Oshima T, Nagano Y, Fujii S, Kimura J, Takagawa R, Kosaka T, Ono HA, Akiyama H, Tanaka K, Endo I.

Anticancer Res. 2010 Jun;30(6):2367-76.

PMID:
20651395
14.

Detailed pathologic characteristics of the primary colorectal tumor independently predict outcome after hepatectomy for metastases.

Cardona K, Mastrodomenico P, D'Amico F, Shia J, Gönen M, Weiser MR, Paty PB, Kingham TP, Allen PJ, De Matteo RP, Fong Y, Jarnagin WR, D'Angelica MI.

Ann Surg Oncol. 2013 Jan;20(1):148-54. doi: 10.1245/s10434-012-2540-y. Epub 2012 Jul 31.

PMID:
22847127
15.

Clinicopathological and prognostic features of hepatoid adenocarcinoma of the stomach.

Zhang JF, Shi SS, Shao YF, Zhang HZ.

Chin Med J (Engl). 2011 May;124(10):1470-6.

PMID:
21740800
16.

Resection of liver metastases in patients with breast cancer: survival and prognostic factors.

van Walsum GA, de Ridder JA, Verhoef C, Bosscha K, van Gulik TM, Hesselink EJ, Ruers TJ, van den Tol MP, Nagtegaal ID, Brouwers M, van Hillegersberg R, Porte RJ, Rijken AM, Strobbe LJ, de Wilt JH; Dutch Liver Surgeons Group.

Eur J Surg Oncol. 2012 Oct;38(10):910-7. doi: 10.1016/j.ejso.2012.04.015. Epub 2012 Jun 7.

PMID:
22682709
17.

Surgical outcome of metachronous hepatic metastases secondary to gastric cancer.

Choi SB, Song J, Kang CM, Hyung WJ, Kim KS, Choi JS, Lee WJ, Noh SH, Kim CB.

Hepatogastroenterology. 2010 Jan-Feb;57(97):29-34.

PMID:
20422867
18.

Long-term survival and prognostic factors in patients with metastatic gastric cancers treated with chemotherapy in the Japan Clinical Oncology Group (JCOG) study.

Yoshida M, Ohtsu A, Boku N, Miyata Y, Shirao K, Shimada Y, Hyodo I, Koizumi W, Kurihara M, Yoshida S, Yamamoto S.

Jpn J Clin Oncol. 2004 Nov;34(11):654-9.

PMID:
15613554
19.

Evaluation of aggressively treated patients with unresectable multiple liver metastases from colorectal cancer.

Miyanari N, Mori T, Takahashi K, Yasuno M.

Dis Colon Rectum. 2002 Nov;45(11):1503-9.

PMID:
12432299
20.

Combination of percutaneous radiofrequency ablation and systemic chemotherapy are effective treatment modalities for metachronous liver metastases from gastric cancer.

Hwang JE, Kim SH, Jin J, Hong JY, Kim MJ, Jung SH, Shim HJ, Bae WK, Hwang EC, Kim JW, Shin SS, Jeong O, Park YK, Cho SH, Chung IJ.

Clin Exp Metastasis. 2014 Jan;31(1):25-32. doi: 10.1007/s10585-013-9606-5. Epub 2013 Aug 22.

Supplemental Content

Support Center